Found: 15
Select item for more details and to access through your institution.
Immunological effects of everolimus in patients with metastatic renal cell cancer.
- Published in:
- International Journal of Immunopathology & Pharmacology, 2017, v. 30, n. 4, p. 341, doi. 10.1177/0394632017734459
- By:
- Publication type:
- Article
IL-10 Conditioning of Human Skin Affects the Distribution of Migratory Dendritic Cell Subsets and Functional T Cell Differentiation.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0070237
- By:
- Publication type:
- Article
The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1553, doi. 10.1007/s00262-022-03350-x
- By:
- Publication type:
- Article
Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 6, p. 1025, doi. 10.1007/s00262-019-02320-0
- By:
- Publication type:
- Article
A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 10, p. 1505, doi. 10.1007/s00262-018-2198-9
- By:
- Publication type:
- Article
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1480, doi. 10.1007/s00262-006-0142-x
- By:
- Publication type:
- Article
The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.545385
- By:
- Publication type:
- Article
NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 4, p. 688, doi. 10.1002/ijc.33859
- By:
- Publication type:
- Article
Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 334, p. 1, doi. 10.1126/scitranslmed.aad8307
- By:
- Publication type:
- Article
Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-152
- By:
- Publication type:
- Article
IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients.
- Published in:
- 2013
- By:
- Publication type:
- journal article
EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0203402
- By:
- Publication type:
- Article
CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis.
- Published in:
- European Journal of Immunology, 2008, v. 38, n. 11, p. 3050, doi. 10.1002/eji.200838384
- By:
- Publication type:
- Article